205 related articles for article (PubMed ID: 33039854)
1. Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease.
Eryilmaz IE; Erer S; Zarifoglu M; Egeli U; Karakus E; Yurdacan B; Cecener G; Tunca B; Colakoglu B; Bora Tokcaer A; Saka E; Demirkiran M; Akbostanci C; Dogu O; Kaleagasi H; Kenangil G; Cakmur R; Elibol B
Clin Neurol Neurosurg; 2020 Dec; 199():106257. PubMed ID: 33039854
[TBL] [Abstract][Full Text] [Related]
2. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
3. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.
Hassan A; Heckman MG; Ahlskog JE; Wszolek ZK; Serie DJ; Uitti RJ; van Gerpen JA; Okun MS; Rayaprolu S; Ross OA
Parkinsonism Relat Disord; 2016 Jan; 22():102-5. PubMed ID: 26627941
[TBL] [Abstract][Full Text] [Related]
4. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
5. Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
Rieck M; Schumacher-Schuh AF; Altmann V; Callegari-Jacques SM; Rieder CRM; Hutz MH
Pharmacogenomics J; 2018 Jan; 18(1):196-200. PubMed ID: 27779245
[TBL] [Abstract][Full Text] [Related]
6. Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy.
Zhang R; Li J; Wu Y; Liang S; Xu L
Genet Test Mol Biomarkers; 2021 Jan; 25(1):20-30. PubMed ID: 33372861
[No Abstract] [Full Text] [Related]
7. Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S; Rajan R; Banerjee M; Kumar H; Sarma G; Krishnan S; Sarma S; Kishore A
Parkinsonism Relat Disord; 2016 Sep; 30():13-7. PubMed ID: 27325396
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
Masellis M; Collinson S; Freeman N; Tampakeras M; Levy J; Tchelet A; Eyal E; Berkovich E; Eliaz RE; Abler V; Grossman I; Fitzer-Attas C; Tiwari A; Hayden MR; Kennedy JL; Lang AE; Knight J;
Brain; 2016 Jul; 139(Pt 7):2050-62. PubMed ID: 27190009
[TBL] [Abstract][Full Text] [Related]
9. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients.
Liu YZ; Tang BS; Yan XX; Liu J; Ouyang DS; Nie LN; Fan L; Li Z; Ji W; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Jul; 65(7):679-83. PubMed ID: 19396436
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.
Arbouw ME; Movig KL; Egberts TC; Poels PJ; van Vugt JP; Wessels JA; van der Straaten RJ; Neef C; Guchelaar HJ
Eur J Clin Pharmacol; 2009 Dec; 65(12):1245-51. PubMed ID: 19669131
[TBL] [Abstract][Full Text] [Related]
11. Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH; García-Ruiz PJ; Martínez-García C; Martínez-Castrillo JC; Vela L; Mata M; Martínez-Torres I; Feliz-Feliz C; Palau F; Hoenicka J
Parkinsonism Relat Disord; 2018 Apr; 49():100-103. PubMed ID: 29361389
[TBL] [Abstract][Full Text] [Related]
12. Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.
Moyer RA; Wang D; Papp AC; Smith RM; Duque L; Mash DC; Sadee W
Neuropsychopharmacology; 2011 Mar; 36(4):753-62. PubMed ID: 21150907
[TBL] [Abstract][Full Text] [Related]
13. Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD.
Wang J; Liu ZL; Chen B
Neurology; 2001 Jun; 56(12):1757-9. PubMed ID: 11425949
[TBL] [Abstract][Full Text] [Related]
14. Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese.
Zheng C; Shen Y; Xu Q
Neurosci Lett; 2012 Jun; 518(1):41-4. PubMed ID: 22569179
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
Juyal RC; Das M; Punia S; Behari M; Nainwal G; Singh S; Swaminath PV; Govindappa ST; Jayaram S; Muthane UB; Thelma BK
Neurogenetics; 2006 Nov; 7(4):223-9. PubMed ID: 16816977
[TBL] [Abstract][Full Text] [Related]
16. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
Oliveri RL; Annesi G; Zappia M; Civitelli D; De Marco EV; Pasqua AA; Annesi F; Spadafora P; Gambardella A; Nicoletti G; Branca D; Caracciolo M; Aguglia U; Quattrone A
Mov Disord; 2000 Jan; 15(1):127-31. PubMed ID: 10634251
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of
Dai D; Wang Y; Wang L; Li J; Ma Q; Tao J; Zhou X; Zhou H; Jiang Y; Pan G; Xu L; Ru P; Lin D; Pan J; Xu L; Ye M; Duan S
Biomed Rep; 2014 Mar; 2(2):275-281. PubMed ID: 24649110
[TBL] [Abstract][Full Text] [Related]
18. The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease.
Zapała B; Stefura T; Piwowar M; Czekalska S; Zawada M; Hadasik M; Solnica B; Rudzińska-Bar M
J Mol Neurosci; 2022 Apr; 72(4):812-819. PubMed ID: 35044623
[TBL] [Abstract][Full Text] [Related]
19. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.
Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J
Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor D2 intronic polymorphism in patients with Parkinson's disease.
Pastor P; Muñoz E; Obach V; Martí MJ; Blesa R; Oliva R; Tolosa E
Neurosci Lett; 1999 Oct; 273(3):151-4. PubMed ID: 10515181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
